Home › Leucemia mieloide acuta › Michigan › Ann Arbor
Studi clinici su Leucemia mieloide acuta a Ann Arbor, MI
17 studi su Leucemia mieloide acuta cercano partecipanti presso sedi a Ann Arbor e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · a 7 mi di distanza
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · a 15 mi di distanza
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · a 18 mi di distanza
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
In reclutamentoFase 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · a 7 mi di distanza
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · a 15 mi di distanza
- e altri 1
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
In reclutamentoFase 1
- C S Mott Children's Hospital, Ann Arbor
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · a 7 mi di distanza
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · a 7 mi di distanza
- e altri 4
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · a 7 mi di distanza
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · a 15 mi di distanza
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · a 18 mi di distanza
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
In reclutamentoFase 3
- Trinity Health Michigan Heart - Ann Arbor Campus, Ypsilanti · a 7 mi di distanza
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · a 7 mi di distanza
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · a 15 mi di distanza
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · a 18 mi di distanza
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · a 7 mi di distanza
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · a 15 mi di distanza
- e altri 1
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · a 7 mi di distanza
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · a 15 mi di distanza
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · a 18 mi di distanza
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
In reclutamentoFase 3
- C S Mott Children's Hospital, Ann Arbor
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
In reclutamentoFase 3
- C S Mott Children's Hospital, Ann Arbor
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
In reclutamentoFase 1/2
- C S Mott Children's Hospital, Ann Arbor
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
In reclutamentoFase 3
- C.S. Mott Children's Hospital, Ann Arbor
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
In reclutamentoFase 3
- University of Michigan, Ann Arbor
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
In reclutamentoStudio osservazionale
- University of Michigan, Ann Arbor
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
In reclutamentoFase 1
- University of Michigan, Ann Arbor
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
In reclutamentoFase 1
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Studi su Leucemia mieloide acuta in altre città
- Houston, TX85 studi
- New York City, NY51 studi
- Boston, MA44 studi
- Seattle, WA41 studi
- Baldwin Park, CA40 studi
- Columbus, OH35 studi
- Philadelphia, PA34 studi
- Durham, NC33 studi
- Atlanta, GA31 studi
- Tampa, FL29 studi
- Chicago, IL26 studi
- Portland, OR25 studi
Altri studi a Ann Arbor
- Cancro al seno27 studi
- Cancro alla prostata27 studi
- Cancro del polmone non a piccole cellule26 studi
- Cancro (tutti i tipi)25 studi
- Cancro ai polmoni23 studi
- Cancro colorettale23 studi
- Insufficienza cardiaca22 studi
- Malattie cardiovascolari16 studi
- Cancro pancreatico14 studi
- Melanoma12 studi
- Ictus12 studi
- Carcinoma a cellule squamose della testa e del collo12 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.